4 stocks to watch on Friday: MRK, NU, GAP, BMY

4 stocks to watch on Friday: MRK, NU, GAP, BMY
4 stocks to watch on Friday: BMY, QCOM, MOS, LOW
Karuna Therapeutics drops on no apparent news amid deal with Bristol-Myers Squibb
Stocks making the biggest premarket moves: META, AMZN, BMY, CVX - CNBC
Bristol-Myers Squibb top M&A exec Mily departing company
128.85BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US1101221083
CUSIP
110122108
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
18.17
PEG Ratio
1.64
Book Value
9.83
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
3.57
Wall Street Target Price
62.96
EPS Estimate Current Year
6.34
EPS Estimate Next Year
6.19
EPS Estimate Current Quarter
1.4216
EPS Estimate Next Quarter
1.6356
Most Recent Quarter
-
Revenue TTM
48,482,000,896
Gross Profit TTM
34,898,001,920
EBITDA
18,973,999,104
Profit Margin
15.01%
Return On Assets TTM
10.69%
Return On Equity TTM
38.73%
Revenue Per Share TTM
23.815
Qtly Revenue Growth YOY
2.60%
Diluted Eps TTM
3.57
Qtly Earnings Growth YOY
9.20%
Trailing PE
18.17
Forward PE
9
Price Sales TTM
2.7319
Price Book MRQ
6.4209
Enterprise Value Revenue
3
Enterprise Value EBITDA
10
257.79
0.66%130.24
0.29%158.52
0.00%251.85
-2.38%54.64
-1.14%156.60
-1.11%169.64
-1.02%1150.00
-0.53%423.20
-0.44%439.41
-0.13%Curated watchlists where BMY is featured.